PRQR

#6352
ProQR Therapeutics N.V. Ordinary Shares
1.59
+3.25%
Secteur:
Base:
Devise de Profit:
Range quotidien
1.59
1.59
Range Annuel
1.07
3.10
Changement quotidien
+3.25%
Changement Mensuel
-4.79%
Evolution sur 6 mois
-28.05%
Changement Annuel
-32.91%
Clôture Précédente
1.54
Open
1.59
Bid
Ask
Low
1.59
High
1.59
Volume
6
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

ProQR Therapeutics N.V

ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer.

Nouvelles